Robert Moore
Analyst · Alex Kramm with UBS
Okay. Hey, Alex. It’s Robert. So, these products are complex. They do require additional attention, which as Mark says, we are well positioned to provide our research group, which has about 50 people in it, 23 CFAs, a group specifically dedicated to alternative investments, which includes non-traded REITs, fund of funds, BDCs, other types of instruments, which again overall comprise less than 10% of our total activity, but are very important, particularly during a period of caution and search for yield. So, the scrutiny at the frontend around due diligence is exceptionally deep and consistent. Importantly, we don’t grant exceptions. We look – look to a very well established process and we adhere to that process. And we have a very experienced team that does that. In addition, advisor training education, certification, of course, is required on many of these products. And again, we don’t look for any exceptions in that process. We strictly adhere to that process. And then finally, of course, we diligent the end customer, and their sophistication level, level of assets, et cetera to make sure that it is an appropriate investment in their overall financial plan. So, that is the full watershed of activity that you can do to mitigate, and help to reduce the level of risk. You’ll never empty it altogether, but our track record is exceptionally good and we continue to believe that these products have an appropriate place and appropriate use against that kind of construct.
Alex Kramm – UBS: Okay. So, I guess just put it to rest, we shouldn’t get too worried about some of these headlines and some of the FINRA warnings and things like that impacting you any time soon here.